GENEVA, July 3 -- KALLYOPE, INC. (430 East 29th Street, 10th FloorNew York, New York 10016) filed a patent application (PCT/US2024/060486) for "GPR40 AGONISTS" on Dec 17, 2024. With publication no. WO/2025/136929, the details related to the patent application was published on Jun 26, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): NEELAMKAVIL, Santhosh F. (430 East 29th Street, 10th FloorNew York, New York 10016), HE, Shuwen (430 East 29th Street, 10th FloorNew York, New York 10016)
Abstract:
This disclosure is directed, at least in part, to GPR40 agonists useful for the treatment of cond...